Artivion, Inc. Data Breach — Case File

From the AG filing description

Artivion, Inc. operates as a major medical device and cardiac surgery company, specializing in the manufacturing and distribution of aortic stent grafts, surgical sealants, and preserved human heart tissues and vascular grafts. Because of its core operations within the medical technology and life sciences sector, Artivion routinely handles an immense volume of highly sensitive information. This includes not only proprietary corporate data and clinical trial records, but also extensive protected health information (PHI), patient registry records, and personally identifiable information (PII) belonging to surgical patients, healthcare providers, clinical researchers, and company employees. The security incident reported to the Texas Attorney General in 2025 highlights vulnerabilities common to high-value life sciences and medical technology enterprises. While the exact vector remains under investigation, incidents in the healthcare and medical device sector frequently involve sophisticated ransomware attacks, unauthorized access to enterprise resource planning databases, or compromises of third-party vendor networks and supply chain software. In an industry where interconnected digital infrastructure is critical for global distribution and clinical coordination, a single point of failure can grant unauthorized external actors deep access to confidential internal networks and centralized data repositories. A breach of this magnitude inevitably exposes deeply sensitive categories of personal data, each carrying distinct and severe risks for the affected individuals. Exposure of names, dates of birth, Social Security numbers, and contact details leaves victims immediately vulnerable to identity theft and tax fraud. Furthermore, given Artivion's role in cardiac surgery and medical devices, compromised records may include specific medical device tracking details, surgical procedure dates, and healthcare provider associations. The exposure of medical and surgical history is particularly dangerous, as it strips individuals of their medical privacy and creates significant avenues for targeted medical fraud, phishing schemes designed to exploit healthcare anxieties, and unauthorized access to health insurance accounts. As an entity operating within the healthcare and life sciences ecosystem, Artivion was bound by stringent legal duties to secure this sensitive information. Depending on the nature of the data collected, these obligations stem from state data privacy statutes, the Texas Identity Theft Enforcement and Protection Act, and applicable federal standards including the Health Insurance Portability and Accountability Act (HIPAA) Security and Privacy Rules. These frameworks mandate the implementation of robust administrative, physical, and technical safeguards—such as multi-factor authentication, end-to-end encryption, network segmentation, and regular vulnerability assessments. The occurrence of a widespread data breach strongly suggests that these mandated security controls may have been inadequate or improperly maintained, pointing to potential negligence in data protection practices. For individuals who have received an official data breach notification letter from Artivion, Inc., this document serves as formal legal acknowledgment that your personal and potentially confidential health data was compromised due to corporate security failures. Legally, the receipt of this notice establishes the concrete injury and standing necessary to participate in a class action lawsuit aimed at holding the company accountable. Importantly, affected individuals do not need to demonstrate that they have already suffered direct financial loss or medical identity theft to pursue legal remedies; the increased, imminent risk of future harm is sufficient. Our law firm is actively investigating this breach on a contingency fee basis, meaning there are never any out-of-pocket costs or upfront fees, and clients pay nothing unless we successfully recover compensation on their behalf.